Merck's cholesterol pill gets US FDA approval - Reuters
Merck's cholesterol pill gets US FDA approval Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNLVVrMEhiYUJsRW5aTnhRMjJsMHpYTEdsUC00dzdUNUNGYXljTzNTeEc3Nmw2ZkV5RmZHRmhabHBub0FhZDVWTW83dmUwMkJoaGJYT1dmZndsUmNjenlQOWxFQzF4engwMktlb1pEQzJHU0ZQelhoVTQ0aFZtX3AyY1ozOEF1MmgzX3JvQlVfWENtcGJFYXppS0l1cmRQZw?oc=5" target="_blank">Merck's cholesterol pill gets US FDA approval</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Novo Nordisk to license experimental GLP-1 pill from China's Hengrui - Reuters
Novo Nordisk to license experimental GLP-1 pill from China's Hengrui Reuters
September 29, 2026 at 04:47 AMExperimental Lilly combination drug tops Zepbound in weight-loss trial - Reuters
Experimental Lilly combination drug tops Zepbound in weight-loss trial Reuters
September 30, 2026 at 05:34 PMFDA seeks scientists and consumer representatives for advisory panels - reuters.com
FDA seeks scientists and consumer representatives for advisory panels reuters.com
September 30, 2026 at 08:30 PMUS FDA extends review of Novo Nordisk's hemophilia drug over facility issues - Reuters
US FDA extends review of Novo Nordisk's hemophilia drug over facility issues Reuters
October 2, 2026 at 09:52 PMAstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination Reuters
October 2, 2026 at 06:58 AMNovo says Ozempic shows lower risk of cardiovascular events compared to Lilly's Mounjaro - reuters.com
Novo says Ozempic shows lower risk of cardiovascular events compared to Lilly's Mounjaro reuters.com
September 29, 2026 at 09:49 PM